LSTCON 2020 featured discussions on managing a business amid the pandemic, support for innovative policies and treatment of rare disease. View our 2020 agenda.
LSTCON 2020 speakers are industry leaders in innovative diagnostics, drugs and therapies, medical devices, investment and economic growth and regulatory issues. Here’s a snapshot of some of our 2020 speakers.
David Adair, MDCo-Founder and Managing Director, Solas BioVentures
Jenn AdamsCEO, August Bioservices
Kayla GraffCo-Founder and CEO, SweetBio
Clayton HallEVP, Government Affairs, Medical Device Manufacturers Association
Daniel C. Liebler, PhDPresident and CEO, Protypia, Inc.
Nick MagallanesVice President, PhRMA
Sen. Shane Reeves (R-14)Tennessee General Assembly
Rep. Phil Roe, MD (R-1)U.S. House of Representatives
Danielle SloaneMember, Bass, Berry & Sims
Save the date: LSTCON will be held November 9, 2021 in Nashville.
Registration will open later.
The Venture Forum, sponsored by Waller, gives a platform to emerging life science startups to access funding and potential investment opportunities, as well as marketing support. Each company had 10 minutes to pitch before a panel of judges who evaluated each team on IP and commercialization strategy. Finalists competed for a $5k prize awarded by Waller.
Congratulations to this year’s Venture Forum winner, Ichor Sciences! Ichor Sciences is a Nashville-based company that has developed the StatBond, a hemostatic device built to provide both a localized sealant to prevent blood loss and a physical scaffold the body can use to build a clot.
LSTCON is a powerful gathering for Tennessee’s life science industry to share the latest innovations moving the industry forward. Build connections and advance your brand among industry thought leaders and innovators.